In addition, the occurrence of mutations in the gene encoding OPA1 are associated with autosomal dominant optic atrophy (ADOA) and ADOA+ syndromes, characterized by visual loss and in the latter case also by more widespread neurological symptoms [6–8]. This evidence concerns the gene OPA1 and autosomal dominant optic atrophy.